Global Markets Direct’s pharmaceuticals report, “PregLem SA - Product Pipeline Review - 2013” provides data on the PregLem SA’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, PregLem SA’s corporate website, SEC filings, investor presentations and featured press releases, both from PregLem SA and industry-specific third party sources, put together by Global Markets Direct’s team.
- PregLem SA - Brief PregLem SA overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of PregLem SA human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of PregLem SA with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the PregLem SA’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate PregLem SA’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of PregLem SA in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the PregLem SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with PregLem SA. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of PregLem SA and identify potential opportunities in those areas.
Table Of Contents
PregLem SA - Product Pipeline Review - 2013 Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 PregLem SA Snapshot 4 PregLem SA Overview 4 Key Information 4 Key Facts 4 PregLem SA - Research and Development Overview 5 Key Therapeutic Areas 5 PregLem SA - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 PregLem SA - Pipeline Products Glance 9 PregLem SA Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 PregLem SA - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 PregLem SA - Drug Profiles 11 bentamapimod 11 Product Description 11 Mechanism of Action 11 RandD Progress 11 PGL-1001 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 PGL-2001 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 PGL-3001 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 PregLem SA - Pipeline Analysis 15 PregLem SA - Pipeline Products by Therapeutic Class 15 PregLem SA - Pipeline Products By Target 16 PregLem SA - Pipeline Products by Route of Administration 17 PregLem SA - Pipeline Products By Mechanism of Action 18 PregLem SA - Recent Pipeline Updates 19 PregLem SA - Dormant Projects 20 PregLem SA - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 23 Disclaimer 23
List of Tables
PregLem SA, Key Information 4 PregLem SA, Key Facts 4 PregLem SA - Pipeline by Indication, 2013 6 PregLem SA - Pipeline by Stage of Development, 2013 7 PregLem SA - Monotherapy Products in Pipeline, 2013 8 PregLem SA - Phase II, 2013 9 PregLem SA - Preclinical, 2013 10 PregLem SA - Pipeline By Therapeutic Class, 2013 15 PregLem SA - Pipeline By Target, 2013 16 PregLem SA - Pipeline By Route of Administration, 2013 17 PregLem SA - Pipeline Products By Mechanism of Action, 2013 18 PregLem SA - Recent Pipeline Updates, 2013 19 PregLem SA - Dormant Developmental Projects,2013 20
List of Figures
PregLem SA - Pipeline by Indication, 2013 6 PregLem SA - Pipeline by Stage of Development, 2013 7 PregLem SA - Monotherapy Products in Pipeline, 2013 8 PregLem SA - Pipeline By Therapeutic Class, 2013 15 PregLem SA - Pipeline Products By Mechanism of Action, 2013 18